# Sandoz

> Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. Last analyzed August 9, 2026.

> Sandoz is a pharmaceutical company dedicated to pioneering access for patients by offering a wide range of generic and biosimilar medications across various therapeutic areas, complemented by robust patient support programs and clear channels for medical inquiries and safety reporting.

- Business Profile: https://optimly.ai/brand/sandoz-novartis
- Publisher: Optimly (https://optimly.ai)
- Dataset: Optimly AI Brand Index (https://optimly.ai/brand)
- Official website: https://patients.my-sandoz.com/
- Logo: https://logo.clearbit.com/patients.my-sandoz.com
- Slug: sandoz-novartis
- Brand Authority Index tier: Emerging
- Archetype: Incumbent
- Category: Pharmaceuticals
- Last Analyzed: August 9, 2026

## Buyer Intent Signals
Problems: Manual Drug Information Search & Support: Patients and healthcare providers would need to manually research drug options, dosages, potential side effects, and available support programs without a cent | Third-Party Patient Services Agency: An external agency could manage patient support programs, medical inquiries, and adverse event reporting, acting as an intermediary between the patient/HCP and the | No Dedicated Patient Access & Support: Without Sandoz's initiatives, patients might face greater barriers to accessing affordable medications and support, leading to poorer health outcomes and higher 
Solutions: Sandoz therapeutic areas | Sandoz patient support programs | About Sandoz Canada | Sandoz medical information | General Healthcare Information Platforms: Reliance on broader, non-brand-specific healthcare information websites or general drug databases for medication details, potentially lacking specific patient